
Malissa Magiera
Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s <em>Teva v. GSK </em>Decision
Biosimilars Law Bulletin ·
Tysabri® (natalizumab) Litigation Begins
Biosimilars Law Bulletin ·
Purple Book Update – Regeneron’s EYLEA (aflibercept)
Biosimilars Law Bulletin ·